Dopamine D2 and serotonin 5-HT2A receptors (antagonist) drugs for Bipolar Disorder

12 tracked Dopamine D2 and serotonin 5-HT2A receptors (antagonist) drugs in the Bipolar Disorder race. The class explanation lives on the Dopamine D2 and serotonin 5-HT2A receptors (antagonist) page; the full indication pipeline across every mechanism is on the Bipolar Disorder page.

11 approved / phase 41 Phase 3

Head-to-head evidence: Asenapine vs Loxapine (Adasuve) · Asenapine vs Milsaperidone (VHX-896) · Iloperidone (Fanapt) vs Loxapine (Adasuve) · Iloperidone (Fanapt) vs Milsaperidone (VHX-896) · Loxapine (Adasuve) vs Milsaperidone (VHX-896) · Loxapine (Adasuve) vs Olanzapine (Zyprexa)

The roster

← all Dopamine D2 and serotonin 5-HT2A receptors (antagonist) drugs